Longevity by Design

• Precision Longevity Medicine with Dr. David Barzilai

  Can personalized medicine unlock the secrets to living longer and healthier lives? In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. David Barzilai, a renowned longevity physician and founder of Barzilai Longevity Consulting, to explore the science of extending healthspan through precision and innovation.Dr. Barzilai shares his journey into biogerontology and longevity science, unpacking key concepts like the hallmarks of aging, the potential of lifestyle interventions, and the translation of findings from animal models to human health. He highlights how evidence-based lifestyle medicine—centered on nutrition, exercise, sleep, and stress management—can be tailored to individual needs using biomarker-driven strategies for maximum impact.The conversation delves into some of the most promising longevity interventions, from gerotherapeutics to cutting-edge supplements. Dr. Barzilai emphasizes the power of personalized approaches in optimizing healthspan and lifespan, offering listeners practical, science-backed insights to take charge of their longevity journey.Engaging and informative, this episode is essential listening for anyone curious about the future of longevity medicine and the innovations shaping how we age. Guest-at-a-Glance💡 Name: Dr. David Barzilai, MD, PhD💡What he does: Founder and CEO💡Company: Healthspan Coaching LLC💡Noteworthy: Renowned longevity physician integrating science and personalized health strategies.💡 Where to find them: LinkedIn, Twitter  Episode highlights:Introduction: 00:00:00Dr. Barzilai’s Journey into Science: 00:03:43The Importance of Translating Science into Practice: 00:10:00The Role of Social Media in Longevity Science: 00:16:37Defining Biogerontology: 00:22:32Understanding the Hallmarks of Aging: 00:24:27The Role of Lifestyle Medicine in Preventing Premature Mortality: 00:36:13Caloric Restriction and Its Effects on Lifespan: 00:37:33Human Trials and the Challenges of Compliance: 00:41:13The Potential of Rapamycin and mTOR Inhibitors: 00:42:05The Importance of Lifestyle Medicine: 00:51:25Precision Medicine: Tailoring Health Interventions: 01:02:56GLP-1 and Alcohol Absorption: 01:12:30Exercise and Mortality Reduction: 01:15:33Biomarkers and Metabolic Health: 01:19:38Longevity Drugs and Supplements: 01:25:43Epigenetic Reprogramming and Aging: 01:45:06For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

  --------  

  1:51:36
• How Can a Nutrition AI Platform Help Us Live Healthier and Longer Lives with Dr. Dmitriy Richard Starson

  On this episode of Longevity by Design, Dr. Gil Blander hosts Dr. Dmitriy Richard Starson, Founder and CEO of Passio, an AI-powered nutrition coaching platform. Dmitriy discusses his career path from astrophysics to the world of nutrition tracking. He explains how his company seeks to make healthy eating more accessible. Passio aims to achieve this through user-friendly technology like food scanning, voice logging, and personalized AI coaching.Dmitriy believes this technology will revolutionize how people approach nutrition. He envisions a future where food tracking is as commonplace as step tracking. This shift, combined with insights from companies like InsideTracker, could lead to personalized nutrition and supplementation plans. Such advances have the potential to slow or even reverse aging and age-related diseases.While acknowledging the influence of the food industry, Dmitriy remains optimistic. He sees a future where individuals have the knowledge and tools to make informed decisions about their health. Through personalized nutrition and data-driven insights, people can optimize their health and work toward increased longevity.Episode highlights:Introduction: 00:00:00From Astrophysics to Nutrition: An Unlikely Journey?: 00:06:00The Power of AI in Food Logging: 00:11:00The "Human" Factor: Addressing Challenges with Data Accuracy: 00:22:00AI and the Healthcare System: A Balancing Act?: 00:45:00Top tip to improve healthspan: 00:50:00We Appreciate You!As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcastFor science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

  --------  

  56:24
• The Path to a 1,000-Year Lifespan with Dr. Aubrey de Grey

  In this episode of Longevity by Design, our host Dr. Gil Blander welcomes Dr. Aubrey de Grey, a biomedical gerontologist, to explore the frontiers of aging research and lifespan extension. Dr. de Grey shares his work identifying and addressing the seven major categories of aging-related diseases. He discusses how targeted damage repair offers a promising alternative to traditional methods to slow aging, providing a path to longer, healthier lives.The conversation delves into the hallmarks of aging, their implications for medical research, and the challenges of translating results from animal models to human applications. Dr. de Grey emphasizes the importance of combining multiple interventions, such as senolytics, gene therapy, and stem cell treatments, to achieve significant gains in lifespan. He also shares insights from his work with the LEV Foundation and the Methuselah Foundation.Listeners will gain a deeper understanding of the science behind rejuvenation and the potential for humanity to reach longevity escape velocity within the coming decades. Dr. de Grey underscores the critical role of continued research, innovation, and funding in accelerating progress toward defeating aging-related diseases. Episode highlights:Introduction: 00:00:00The Seven Hallmarks of Aging: A Foundational Framework: 00:07:00Challenges in Funding Longevity Research: 00:15:00Lifestyle, Genetics, and the Limits of Current Longevity: 00:23:00The Methuselah Foundation and Early Longevity Advocacy: 00:37:00Top tip to improve healthspan: 00:52:00We Appreciate You!As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcastFor science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

  --------  

  53:55
• Dietary Changes to Reduce the Risk of Prostate Cancer with Dr. John Erdman

  On this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. John Erdman to discuss prostate cancer and the impact of diet on disease progression. John shares his personal connection to this disease and why he’s dedicated his research to understanding dietary interventions.John explains that prostate cancer is often slow-growing, with most men experiencing decades between early mutations and noticeable tumor growth. He stresses the importance of early detection through regular checkups, including digital exams and PSA tests. While the medical community debates the effectiveness of these tests, John advocates for establishing a baseline to monitor for any sudden changes.John's research reveals a strong link between tomato consumption and reduced prostate cancer risk. He believes this protective effect stems from lycopene and its metabolites, which may influence gene expression. John emphasizes that while tomato consumption shows promise, maintaining a healthy weight and regular exercise are equally crucial for long-term health. Episode highlights:Introduction: 00:00:00The Stages and Progression of Prostate Cancer: 00:06:00Diagnosing Prostate Cancer: Methods and Considerations: 00:11:00The Role of Specific Foods in Prostate Cancer Risk Reduction: 00:22:00Exploring the Link Between Gut Microbes and Prostate Cancer: 00:30:00Top tip to improve healthspan: 00:34:00For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

  --------  

  37:09
• Unlocking Longevity: Dr. Jens Juul Holst on GLP-1’s Life-Changing Impact on Metabolic Health

  In this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. Jens Juul Holst, a renowned Danish physician and physiologist, to discuss GLP-1, a hormone transforming our understanding of metabolic health. Dr. Holst, who discovered and described GLP-1, explains its role as a gut-derived hormone that regulates appetite, insulin secretion, and digestion, offering a groundbreaking approach to managing obesity and type 2 diabetes.The conversation explores how GLP-1 receptor agonists, have evolved into powerful medications. These drugs help patients achieve significant weight loss, reverse diabetes, improve cardiovascular health, reduce inflammation, and potentially enhance cognitive function. Dr. Holst delves into their long-term implications for preventing diabetes, extending health spans, and even reducing the risks of obesity-related cancers and improving fertility.Dr. Holst emphasizes that while GLP-1 offers life-changing benefits, sustainable health still hinges on balanced diets and regular physical activity. This episode provides a fascinating look at the intersection of science, medicine, and lifestyle in promoting longevity.Episode highlights:Introduction: 00:00:00What is GLP-1: 00:03:00what is a GLP-1 agonist: 00:04:15what are the target organs of the GLP-1 agonist?: 00:06:30what is the effect of the GLP-1 agonist on a diabetic patient?: 00:10:00What percentage of a diabetic patient on GLP-1 have complete remission: 00:11:30How long did it take to bring a drug to market from the moment you first discovered it: 00:23:30What is the GLP-1 effect on cognition and dementia: 00:29:00GLP-1 effect on kidney diseases: 00:32:00GLP-1 positive effect on fertility: 00:35:00GLP-1 positive effect on cancer: 00:37:30Should a patient be on GLP-1 for life: 00:41:00GLP-1 related side effects: 00:48:00GLP-1 effect on resting heart rate: 00:52:30GLP-1 related side effects: 00:48:00GLP-1 from Lilly vs novo nordisk: 00:55:00GLP-1 oral versus the injectable: 00:58:00GLP-1 effect on lifespan: 01:00:30GLP-1 effect on lifespan: 01:00:30What led you to become a scientist: 01:03:00The story of discovering the GLP-1: 01:04:30How did you successfully extend the half-life of the GLP-1 agonist: 01:09:00GLP-1 moving from once a day to once a week: 01:16:00Top tip to improve healthspan: 01:18:00GLP-1 Agonists: A Game-Changer for Diabetes and ObesityDr. Jens Juul Holst explores the revolutionary impact of GLP-1 agonists in treating diabetes and obesity. These medications mimic a natural gut hormone to regulate insulin secretion, appetite, and weight. Through their ability to normalize blood glucose levels and promote significant weight loss, GLP-1 agonists have transformed the lives of patients with type 2 diabetes and obesity. Holst highlights their success in enabling over 50% of diabetes patients to achieve normal glucose levels while addressing the systemic health risks tied to obesity. This innovation represents a monumental leap in metabolic disease management. For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

  --------  

  1:23:16

More Health & Wellness podcasts

Trending Health & Wellness podcasts

About Longevity by Design